The gut microbiota and its related metabolites differ between inflammatory bowel disease
(IBD) patients and healthy controls. In this study, we compared faecal volatile organic …

Abstract Background and Objectives: Inflammatory bowel disease (IBD), including Crohn's
disease (CD) and ulcerative colitis (UC), remains challenging to diagnose. Diagnostic work …

Background Faecal volatile organic compounds (VOCs) differ with disease sub‐type and
activity in adults with established inflammatory bowel disease (IBD) taking therapy. Objective …

Fecal volatile organic compounds (VOCs) are increasingly considered to be potential
noninvasive, diagnostic biomarkers for various gastrointestinal diseases. Knowledge of the …

Endoscopic evaluation is mandatory in establishing the diagnosis of pediatric inflammatory
bowel disease (IBD), but unfortunately carries a high burden on patients. Volatile organic …

In recent years, microbes and their metabolites are increasingly recognised as key players
in the pathogenesis of a wide range of gastrointestinal disorders, such as inflammatory …

The diagnosis of inflammatory bowel disease (IBD) in children and the need to distinguish
between subtypes (Crohn's disease (CD) and ulcerative colitis (UC)) requires lengthy …

Background The aetiology of inflammatory bowel disease (IBD) remains poorly understood.
Recent evidence suggests an important role of gut microbial dysbiosis in IBD, and this may …

Background The diagnostic work-up of pediatric irritable bowel syndrome (IBS) and
functional abdominal pain–not otherwise specified (FAP-NOS) commonly includes invasive …

Background Breath testing is becoming an important diagnostic method to evaluate many
disease states. In the light of rising healthcare costs, is important to develop a simple non …